Example: Heart Attack

Clinical Trials on Cardiac Surgery Requiring Cardiopulmonary Bypass

Total 6 results

NCT00161733

Completed

Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery

Cardiopulmonary Bypass Sternotomy Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy
NCT00914589

Completed

Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass
NCT01562574

Completed

Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass
NCT00154427

Terminated

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass
NCT02239146

Completed

Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass
NCT01153997

Completed

Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

Healthy Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass